Anika Therapeutics (ANIK) Price to Book (2010 - 2026)

Anika Therapeutics (ANIK) has reported Price to Book for 17 consecutive years, with 1.43 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Price to Book rose 38.07% year-over-year to 1.43 in Q2 2026; TTM through Jun 2026 was 1.43, a 38.07% increase from a year earlier, with the FY2025 full-year figure at 0.93, down 39.62% from the prior year.
• Price to Book was 1.43 for Q2 2026 at Anika Therapeutics, down from 1.45 in the prior quarter.
• Over five years, Price to Book peaked at 2.02 in Q3 2024 and troughed at 0.92 in Q3 2025.
• A 5-year average of 1.39 and a median of 1.44 in 2026 frame the typical range for Price to Book.
• Across the five-year window, Price to Book surged 100.16% in 2024 and plunged 54.24% in 2025, its largest moves.
• Over 5 years, Price to Book stood at 1.52 in 2022, then advanced by 3.24% to 1.57 in 2023, then fell by 1.54% to 1.54 in 2024, then plunged by 39.62% to 0.93 in 2025, then soared by 53.3% to 1.43 in 2026.
• The last three Price to Book figures came in at 1.43 (Q2 2026), 1.45 (Q1 2026), and 0.93 (Q4 2025), per Business Quant data.